U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 6637447

Beerbrella

A small umbrella which may be removably attached to a beverage container in order to shade the beverage container from the direct rays of the sun.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 546/142 - Plural chalcogens attached directly to the six-membered hetero ring by nonionic bonding


Subclass of Class 546 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein at least two chalcogens (i.e., oxygen,
No. of patents: 225
Last issue date: 03/18/2008


1            
NumberTitleIssue Date
7345062Substituted acylhydroxamic acids and method of reducing TNFαlevels
Imido and amido substituted acylhydroxamidic acids which reduce the levels of TNFα and inhibit phosphodiesterase in a mammal. A typical embodiment is (3-(1,3-dioxoisoindolin-2-yl)-3-(3-ethoxy-4-methoxyphenyl)propandylamino)propanoate. ...
03/18/2008
7265131Isoquinolinone derivatives and their use as therapeutic agents
Compounds of formula (I): wherein n, R1, R2, R3 and R7 are disclosed herein, are useful in treating disease-states associated with nuclear receptor activity. Pharmaceut...
09/04/2007
7205315Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases
The present invention is directed to a compound of formula (I), or a stereoisomer or a mixture of stereoisomer thereof in any ratio, or its physiologically tolerable salt, which is useful as an inhibitor of matrix metalloproteinase. The present invention is also dir...
04/17/2007
7173057Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of us...
02/06/2007
7153963Phenylalanine derivatives
Specified phenylalanine derivatives and analogues thereof have an antagonistic activity to α4 integrin. They are used as therapeutic agents for various diseases concerning α4 integrin ...
12/26/2006
RE39265Heteroarylpiperidines, and their use as antipsychotics and analgetics
Heteroarylpiperidines, pyrrolidines, and piperazines are useful as antipsychotic and analgesic agents. The compounds are especially useful for treating psychoses by administering to a mammal a psychoses-treating effective amount of one of the compounds. The compound...
09/05/2006
7030201Bottom antireflective coatings
The present invention relates to bottom antireflective coating compositions and polymers useful in making such compositions. ...
04/18/2006
6906063Platelet ADP receptor inhibitors
Novel compounds of formulae (I) to (VIII), which more particularly include sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives whi...
06/14/2005
6870055Isoquinolinone potassium channels inhibitors
The present invention concerns certain isoquinolinone compounds and their utility as inhibitors of voltage-dependent potassium channels or currents, such as Kv1.5 and IKur, that could serve as targets for the treatment of cardiac arrhythmias es...
03/22/2005
6818774Isoquinoline derivatives
Disclosed are isoquinolino derivatives of the formula wherein Y is >C═O or —CH2—, Z is >C═O or —CH2—, and R1, R2 and m are as defined herein as well as the pharma...
11/16/2004
6720427Thiazole derivatives
The invention provides compounds of formula 1 wherein R1, R3, and R4 are as defined, and their pharmaceutically acceptable salts. Compounds of formula 1 are indicated to have activity inh...
04/13/2004
6716853Cyclic N-substituted alpha-imino carboxylic acids for selective inhibition of collogenase
The invention is related to compounds of formula I to pharmaceutical compositions comprising such compounds, to processes for the preparation of such compounds, and to methods of prevention and treatment of disorders, th...
04/06/2004
6699899Substituted acylhydroxamic acids and method of reducing TNF଱ levels
Imido and amido substituted acylhydroxamic acids which reduce the levels of TNF଱ and inhibit phosphodiesterase in a mammal. A typical embodiment is (3-(1,3-dioxoisoindolin-2-yl)-3-(3-ethoxy-4-methoxyphenyl)propanoylamino)p ropanoate....
03/02/2004
6656911Serine protease inhibitors
The present invention relates to certain substituted oxadiazole, thiadiazoles and triazole peptoids which are useful as inhibitors of serine proteases. Compounds of the invention are useful for treating, for example, adult respiratory distress syndrome, s...
12/02/2003
6656910Serine protease inhibitors
The present invention relates to certain substituted oxadiazole, thiadiazoles and triazole peptoids which are useful as inhibitors of serine proteases. Compounds of the invention are useful for treating, for example, adult respiratory distress syndrome, s...
12/02/2003
6602864Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
The compounds of formula I herein exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibit...
08/05/2003
6602867Triazole compounds with dopamine-D3-receptor affinity
Triazole compounds of the following formula ##STR1## where R1, R2, A and B have the meanings given in the description are described. The compounds according to the invention possess a high affinity for the dopamine D3 rece...
08/05/2003
65864473,3-disubstituted-oxindole derivatives useful as anticancer agents
The present invention relates to compounds of formula 1 ##STR1## and to pharmaceutically acceptable salts, prodrugs, and solvates thereof, wherein n is 0 or 1 and R1, R2, R3, R4, and R5 are as defined...
07/01/2003
6479436Hetaroyl cyclohexanedione derivatives with herbicidal effect
Hetaroyl derivatives of the formula I ##STR1## where: R1 and R2 are each hydrogen, nitro, halogen, cyano, thiocyanato, hydroxyl, mercapto, C1 -C6 -alkyl, C1 -C6 -alkoxy, C1 -C
11/12/2002
6472405Glycoprotein IIB/IIIA antagonists
This invention relates to certain bicyclic compounds having a nucleus formed of two fused six membered rings, for example, isoquinoline, isoquinolone, tetrahydronaphthalene, dihydronaphthalene, or tetralone, substituted with both basic and acidic function...
10/29/2002
64520094-unsubstituted dihydroisoquinolinone derivatives and combinatorial libraries thereof
The present invention relates to novel dihydroisoquinolinone (DHQ) derivative compounds of the following formula: ##STR1## wherein R1 to R7, X, Y, Z, b, c and d have the meanings provided herein. The invention further relates to comb...
09/17/2002
6417178Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits
Amyloid binding compounds which are derivatives of Chrysamine G, pharmaceutical compositions containing, and methods using such compounds to identify Alzheimer's brain in vivo and to diagnose other pathological conditions characterized by amyloidosis, suc...
07/09/2002
6403607Sulfonamide derivatives and drugs containing the same as the active ingredient
The present invention discloses a sulfonamide derivative represented by the following formula (1): ##STR1## [wherein A represents a nitrogen atom, --CH.dbd., etc.; Z represents an oxygen atom, etc.; Ar1 represents an aryl group, etc.; Ar2
06/11/2002
6362193Cycloalkenyl substituted compounds
Novel pyridyl or pyrimidinyl substituted cycloalkenyl compounds and compositions for use in therapy....
03/26/2002
6281227Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
The compounds of formula I herein exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibit...
08/28/2001
6262068Lactam derivatives as antiarrhythmic agents
Lactam derivatives of the formula ##STR1## where X is --C(.dbd.O)NR3' --, --NR3' C(.dbd.O)--, --C(.dbd.NCN)NR3' --, --NR3' C(.dbd.NCN)--, --CH2 NR3' --, --CH(alkyl)NR3' --, --CH(...
07/17/2001
6255479Process for the preparation of ଱-oxolactams
A method for preparing an ଱-oxolactam comprising, reacting a corresponding ଱-diazolactam with an oxygen donor, in the presence of a transition metal catalyst, to yield the corresponding ଱-oxolactam....
07/03/2001
6214857Substituted alkanohydroxamic acids and method of reducing TNF଱ levels
Imido and amido substituted alkanohydroxamic acids reduce the levels of TNF଱ and inhibit phosphodiesterase in a mammal. A typical embodiment is 3-(3-cyclopentyloxy-4-methoxyphenyl)-N-hydroxy-3-phthalimidopropionamide....
04/10/2001
6174901Substituted pyridine and pyridazine compounds and methods of use
Selected novel substituted pyridine and pyridazine compounds are effective for prophylaxis and treatment of diseases, such as TNF-଱, IL-1ଲ, IL-6 and/or IL-8 mediated diseases, and other maladies, such as cancer, pain and diabetes. The inventio...
01/16/2001
6168776Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
Amyloid binding compounds which are non-azo derivatives of Chrysamine G, pharmaceutical compositions containing, and methods using such compounds to identify Alzheimer's brain in vivo and to diagnose other pathological conditions characterized by amyloido...
01/02/2001
6166219Benzimidazole derivatives
Novel benzimidazole derivatives represented by the formula (I): ##STR1## wherein R3 is a carboxyl group, a esterified carboxyl group, an amidated carboxyl group, an amino group, an amido group, or a sulfonyl group, or their pharmaceuticall...
12/26/2000
6140339Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof
The present invention provides new monomeric derivatives of the C-8'-7 linked naphthylisoquinoline alkaloid dioncophylline D. The invention also provides new C-4 substituted monomeric arylisoquinoline alkaloid derivatives. The present invention furthermor...
10/31/2000
6040442Process for preparing 1,2,5-thiadiazole containing ethers
The presently claimed process provides a method for preparing compounds of the formula ##STR1## phosphorous (III) compound and a diester of azodicarboxylate....
03/21/2000
6020343(Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases c...
02/01/2000
60158204-Aryl-thio-pyridin-2(1H)-ones, medicines containing them and their uses in the treatment of illnesses linked to HIV
Compounds of formula (3) in which: R1 and R2 independently represent an atom of hydrogen, an aliphatic group or an alkyloxyalkyl group in which the alkyl chains are from C1 to C4 or together form an aromatic ring; R
01/18/2000
5977367N-aminoalkyldibenzofurancarboxamides; new dopamine receptor subtype specific ligands
Disclosed are compounds of the formula: ##STR1## or the pharmaceutically acceptable acid addition salts thereof, wherein: R1, R2, R3, R4 are the same or different and represent hydrogen, C1 -C
11/02/1999
5925637Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids
Matrix metalloprotease inhibiting compounds, pharmaceutical compositions thereof and a method of disease treatment using such compounds are presented. The compounds of the invention have the generalized formulas: ##STR1## wherein r is 0-2, T is selec...
07/20/1999
5866579Imidazole and imidazoline derivatives and uses thereof
This invention is directed to novel imidazole and imidazoline derivatives which are selective agonists for cloned human 댒 adrenergic receptors. This invention is also related to the use of these compounds for the treatment of any disease...
02/02/1999
5861380Serine protease inhibitors-keto and di-keto containing ring systems
The present invention relates to certain substituted oxadiazole, thiadiazole and triazole peptoids which are useful as inhibitors of human neutrophil elastase (HNE) for the treatment of HNE-mediated processes implicated in conditions such as adult respira...
01/19/1999
5837703Amino-alcohol substituted cyclic compounds
Therapeutic compounds have the formula: (X)j-(core moiety), j being an integer from one to three, the core moiety comprising a core moiety, the core moiety being a heterocycle having one ring or two-fused rings, each ring having five or six ring atoms, A being...
11/17/1998
1            
 
Sign InRegister
Username  
Password   
forgot password?